Stem cell therapy, artificial womb technology, and telehealth innovations are reshaping neonatal care and improving outcomes for infants affected by complex conditions, including fetal and neonatal ...

Evaluating HDFN Risk With “Confusing” Blood Group Antibodies, Such as Anti-G, Anti-M ...

A male patient in his 8th decade of life presented with upper eyelid and submandibular swelling that were later diagnosed as immunoglobulin-G4 related disease (IgG4-RD) associated.. An 83-year-old man ...

Next-generation sequencing (NGS) of fetal cell-free DNA from maternal plasma provides a highly accurate and noninvasive approach to determine fetal erythrocyte and platelet antigen status in ...

Risdiplam treatment for 2 years leads to improvements in quality of life in patients with spinal muscular atrophy (SMA), according to a new study published in the scientific journal Neuromuscular ...

An early elevation in serum transthyretin (sTTR) levels in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) treated with acoramidis appears to correlate with improved prognosis, according ...

Researchers from Brazil developed a new clinical score to estimate the probability of neuromyelitis optica spectrum disorder (NMOSD) in patients presenting with optic neuritis.. The easily accessible ...

The Muldoon family from Philadelphia, Pennsylvania, is shown after baby KJ’s infusion of a personalized gene-editing therapy (Photo courtesy of Children’s Hospital of Philadelphia) KJ Muldoon has been ...

A patient with distal acquired demyelinating symmetric neuropathy (DADS) deteriorated and presented with chronic inflammatory demyelinating polyneuropathy (CIDP)-like symptoms after treatment with ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a disorder characterized by progressive, symmetrical muscle weakness and disturbances in the distal upper and lower extremities. While it is ...

Two phase 3 clinical trials, MOBILIZE and VITALIZE, are recruiting patients with chronic demyelinating polyneuropathy (CIDP) to evaluate the effectiveness of riliprubart according to an abstract ...

BOSTON—Artificial intelligence (AI) can bring multifaceted benefits to clinical research efficiency, the drug development pipeline, and patient care, rare disease experts said at the World Orphan Drug ...